BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
595 results:

  • 1. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
    Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
    Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
    Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
    ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BRAF
    Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
    Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
    Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
    Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
    Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
    Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinc F; Catak M; Tekin S; Ozturk BO; Yavuz HC; Kadioglu P; Cinar N; Bayraktaroglu T; Topcu B; Altuntas Y; Elbuken G
    Endocrine; 2024 Mar; 83(3):700-707. PubMed ID: 37736822
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A systematic review on clinical adaptive radiotherapy for head and neck cancer.
    Lindegaard AM; Håkansson K; Bernsdorf M; Gothelf AB; Kristensen CA; Specht L; Vogelius IR; Friborg J
    Acta Oncol; 2023 Nov; 62(11):1360-1368. PubMed ID: 37560990
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Esophageal cancer T-staging on MRI: A preliminary study using cine and static MR sequences.
    Haefliger L; Jreige M; Du Pasquier C; Ledoux JB; Wagner D; Mantziari S; Shäfer M; Vietti Violi N; Dromain C
    Eur J Radiol; 2023 Sep; 166():111001. PubMed ID: 37516096
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A plan comparison study between rapid arc and conventional intensity-modulated radiation treatment plans in nasopharyngeal carcinoma patients.
    Patidar Y; Kumar HS; Sharma N; Mayilvaganan A
    J Cancer Res Ther; 2023; 19(3):543-547. PubMed ID: 37470572
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
    Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
    Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
    Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
    Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Early changes in soluble intracellular adhesion molecule-1 as prognostic biomarkers to immune checkpoint inhibitor.
    Ji D; Jiang S; Zhang Q; Wang YK; Zhang J; Shen W; Li W; Liu R; Wang J; Mavis C; Gu JJ; Hu X
    Clin Transl Sci; 2023 Aug; 16(8):1396-1407. PubMed ID: 37317057
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal cancer.
    Kubo Y; Makino T; Yamasaki M; Tanaka K; Yamashita K; Shiraishi O; Sugimura K; Miyata H; Motoori M; Fujitani K; Takeno A; Hirao M; Kimura Y; Satoh T; Yano M; Eguchi H; Yasuda T; Doki Y
    Ann Surg Oncol; 2023 Sep; 30(9):5899-5907. PubMed ID: 37316744
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
    Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
    Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
    Barale M; Nervo A; Craparo A; Pusterla A; Retta F; Maiorino F; Castellano E; Piovesan A; Gianotti L; Borretta G; Procopio M; Arvat E
    Front Endocrinol (Lausanne); 2023; 14():1158474. PubMed ID: 37223026
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.
    Staubitz JI; Müller C; Heymans A; Merten C; Roos B; Poplawski A; Ludt A; Strobl S; Springer E; Schad A; Roth W; Musholt TJ; Hartmann N
    BJS Open; 2023 May; 7(3):. PubMed ID: 37146205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
    Hue J; Valinciute Z; Thavaraj S; Veschini L
    Oral Oncol; 2023 Jun; 141():106399. PubMed ID: 37098302
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S; Remick J; McDonald M; Abousaud M; Tan AC; Fadlullah MZH; Chaudhary R; Muzaffar J; Kirtane K; Liu Y; Chen GZ; Shin DM; Teng Y; Chung CH
    Nat Med; 2023 Apr; 29(4):880-887. PubMed ID: 37012550
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Magnetic resonance diagnosis of laryngeal chondritis after transoral laser microsurgery for laryngeal cancer.
    Cunha B; Lancini D; Rondi P; Ravanelli M; Maroldi R; Paderno A; Zigliani G; Bertotto I; Piazza C; Farina D
    Acta Otorhinolaryngol Ital; 2023 Feb; 43(1):32-41. PubMed ID: 36860148
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 30.